CWBR - コ―バ― （CohBar Inc.） コ―バ―CWBRのチャート
CWBRの企業情報
| symbol | CWBR |
|---|---|
| 会社名 | CohBar Inc （コ―バ―） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 CohBar Inc. (CohBar) is engaged in the research and development of mitochondria-based therapeutics (MBTs) a class of drugs with potential for the treatment of diseases associated with aging. MBTs originate from the discovery of a group of peptides encoded within the genome of mitochondria. The Company's development of mitochondrial-derived peptides (MDPs) into MBTs offers the potential to address a range of diseases including type 2 diabetes cancer atherosclerosis and neurodegenerative disorders. MDPs represent a diverse and largely unexplored collection of peptides. MOTS-c is an MDP which indicates that it plays a role in the regulation of metabolism. The Company is engaged in the research on MOTS-c and its analogs as its lead program. The Company's academic collaborators have discovered various other MDPs with similar mitochondrial origin to the MDP humanin which the Company refers to as small humanin-like peptides (SHLPs). コ―バ―は米国のバイオ医薬品企業。主に2型糖尿病の治療薬の研究開発に従事する。肥満、脂肪肝疾患、脂肪性肝炎など老化および代謝機能不全に関連する疾患に対する、ミトコンドリアベ―スの治療薬を手掛ける。また、同社はがん、アテロ―ム性動脈硬化症、心臓血管疾患、アルツハイマ―病の治療薬も開発する。本社所在地はカリフォルニア州メンロパ―ク。 CohBar is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria based therapeutics originate from the discovery by CohBar's founders of a novel group of naturally occurring peptide sequences within the mitochondrial genome, some of which have been shown to have the potential to regulate key processes in multiple systems and organs in the body. To date, the company has discovered more than 100 mitochondrial derived peptides and generated over 1,000 analogs. CohBar's efforts focus on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases because of the underlying impact of mitochondrial dysfunction. The company's lead compound, CB4211, is in the Phase 1b stage of a Phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar has 4 preclinical programs: CB5138 Analogs for fibrotic diseases, CB5064 Analogs for COVID-19 associated ARDS, MBT5 Analogs for CXCR4-related cancer and orphan diseases, and MBT3 Analogs for cancer immunotherapy. |
| 本社所在地 | 1455 Adams Drive Suite 2050 Menlo Park CA 94025 USA |
| 代表者氏名 | Albion J. Fitzgerald アルビオンJ.フィッツジェラルド |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 650-446-7888 |
| 設立年月日 | 40057 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | － |
| url | www.cohbar.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cwbr |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -12.39973 |
| 終値（lastsale） | 4.015 |
| 時価総額（marketcap） | 170492140.94 |
| 時価総額 | 時価総額（百万ドル） 163.06100 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 137.73505 |
| 当期純利益 | 当期純利益（百万ドル） -12.59721 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 CohBar Inc revenues was not reported. Net loss increased 67% to $6.9M. Higher net loss reflects Research and development increase of 76% to $4.5M (expense) General and administrative increase of 41% to $2.2M (expense) Amortization of debt discount and offeri increase from $0K to $105K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.12 to -$0.17. |
CWBRのテクニカル分析
CWBRのニュース
CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript 2022/03/30 02:44:02 Seeking Alpha
CohBar GAAP EPS of -$0.04 beats by $0.01 2022/03/29 20:03:30 Seeking Alpha
CohBar press release (CWBR): Q4 GAAP EPS of -$0.04 beats by $0.01.The company had cash and investments of $26.2 million as of December 31, 2021, compared to $21.0 million as of…
CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update 2022/03/29 20:01:00 GlobeNewswire
Conference call and webcast at 5:00 p.m. ET today, March 29, 2022 Conference call and webcast at 5:00 p.m. ET today, March 29, 2022
CohBar Inc Shares Fall 5.0% Below Previous 52-Week Low - Market Mover 2021/12/30 01:38:49 Kwhen Finance
CohBar Inc (CWBR) shares closed 5.0% lower than its previous 52 week low, giving the company a market cap of $31M. The stock is currently down 72.8% year-to-date, down 74.0% over the past 12 months, and down 93.4% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 45.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 141.2% The company's stock price performance over the past 12 months lags the peer average by 137.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
CohBar Inc Shares Fall 5.0% Below Previous 52-Week Low - Market Mover 2021/12/30 01:38:49 Kwhen Finance
CohBar Inc (CWBR) shares closed 5.0% lower than its previous 52 week low, giving the company a market cap of $31M. The stock is currently down 72.8% year-to-date, down 74.0% over the past 12 months, and down 93.4% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 45.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 141.2% The company's stock price performance over the past 12 months lags the peer average by 137.2%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Thinking about buying stock in SeaChange International, American Virtual Cloud Technologies, Quoin Pharmaceuticals, Acasti Pharma, or CohBar? 2021/12/23 15:45:00 Kwhen Finance
CohBar, Inc. (NASDAQ:CWBR) Expected to Post Earnings of -$0.04 Per Share 2021/12/20 04:08:41 Dakota Financial News
Equities analysts expect CohBar, Inc. (NASDAQ:CWBR) to announce ($0.04) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have made estimates for CohBars earnings. CohBar reported earnings per share of ($0.08) in the same quarter last year, which suggests a positive year-over-year growth rate of 50%. The company is []
CohBar announces changes to board of directors, resignation of CSO 2021/12/17 14:28:14 Seeking Alpha
CohBar Announces Changes to its Board of Directors and R&D Leadership 2021/12/17 14:00:00 Intrado Digital Media
Founding board members transition to reconstituted Scientific Advisory Board
CohBar, Inc. (NASDAQ:CWBR) Short Interest Down 73.6% in November 2021/11/30 19:56:42 Transcript Daily
CohBar, Inc. (NASDAQ:CWBR) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 880,400 shares, a drop of 73.6% from the October 31st total of 3,330,000 shares. Based on an average daily trading volume, of 1,790,000 shares, the short-interest ratio is presently 0.5 days. Shares of NASDAQ:CWBR []
CohBars CEO to Participate in Upcoming BIO Webinar 2021/11/29 14:00:00 Intrado Digital Media
MENLO PARK, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced its Chief Executive Officer, Joseph Sarret, MD, JD, will be a participant on the BIO webinar titled Leveraging JPM Week to Achieve Business Development Goals on December 2, 2021 at 1:00pm ET. Registration is complimentary at https://bio-org.zoom.us/webinar/register/WN_j3I6XMIXRQSuf1d2wdoWjw .
Alarming Stock: CohBar, Inc. (NASDAQ:CWBR), Senmiao Technology Limited (NASDAQ:AIHS) 2021/11/29 03:54:00 Stock Equity
CohBar, Inc. (CWBR) with the stream of -2.04% also noticed, India Senmiao Technology Limited (AIHS) encountered a rapid change of 4.30% in the last hour of trading session. CohBar, Inc. The post Alarming Stock: CohBar, Inc. (NASDAQ:CWBR), Senmiao Technology Limited (NASDAQ:AIHS) appeared first on Stocks Equity .
Stock Runner: CohBar, Inc. (NASDAQ:CWBR), Weidai Ltd. (NYSE:WEI) 2021/11/27 00:11:07 Stock Equity
CohBar, Inc. (CWBR) with the stream of -2.04% also noticed, India Weidai Ltd. (WEI) encountered a rapid change of 0.74% in the last hour of Friday’s trading session. CohBar, Inc. … The post Stock Runner: CohBar, Inc. (NASDAQ:CWBR), Weidai Ltd. (NYSE:WEI) appeared first on Stocks Equity .
CohBar, Inc. (NASDAQ:CWBR) Receives Average Recommendation of Buy from Analysts 2021/11/25 17:08:42 Dakota Financial News
CohBar, Inc. (NASDAQ:CWBR) has been given an average rating of Buy by the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock in the last year is $2.38. A number []